Immunology, Oncology and Monitoring

Agenda and Speakers

Enumeration and phenotyping of malignant populations in multiple myeloma patients using multicolor flow cytometry
Bevan Gang, PhD, Principal Scientist, Caprion Biosciences, Inc.

B cell activation and differentiation employ mTORC1 rather than Xbp1 to initiate distinct segments of the unfolded protein response before antibody secretion
Brian Gaudette, PhD, Postdoctoral Researcher, University of Pennsylvania

Mass Cytometry Quality Control Using Heavy Metal-Labeled Reference Spike-In Control Cells
El-ad David Amir, PhD, Chief Executive Officer, Astrolabe Diagnostics, Inc.

A consensus COVID-19 immune signature combines immune protection with discrete sepsis-like traits associated with poor prognosis
Irene del Molino del Barrio, PhD, Senior Technician, University College London

CMLE Credit: 1.0

Components visible upon registration.

NOTE: This event is held in Eastern Daylight time (GMT-4)